SOLENO THERAPEUTICS INC
SLNO$2.66B
Mid CapNASDAQBiotechnology🇺🇸North America152 employees
Drugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
SLNO News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
DCCR | Phase 3 | Prader-Willi Syndrome | - | - |
Market-Implied Move
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply